Healthcare provider profile · identity verified

Jonathan Samuel Waldman, MD

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology · SCHENECTADY, NY · NPI 1669415501

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Jonathan Samuel Waldman, MD received $62.03 in general payments during 2025 across 3 reported records.

AstraZeneca Pharmaceuticals LP accounted for 71.5% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Brilinta by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 192 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Lokelma by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 36 claims for Symbicort by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$62.03

3 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$44.35	71.5%	2	2025
Teva Pharmaceuticals USA, Inc.	Unresolved — no canonical attribution shown	$17.68	28.5%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$62.03	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
BREZTRI Normalized: breztri	Drug	AstraZeneca Pharmaceuticals LP	$44.35	2	2025
Source payment records 2025-06-16 · AstraZeneca Pharmaceuticals LP · $22.66 · Open Payments source 2025-06-18 · AstraZeneca Pharmaceuticals LP · $21.69 · Open Payments source
AUSTEDO XR Normalized: austedo xr	Drug	Teva Pharmaceuticals USA, Inc.	$17.68	1	2025
Source payment records 2025-09-29 · Teva Pharmaceuticals USA, Inc. · $17.68 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	BRILINTA open payments reported associated product	CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430	Brilinta · 2024 Exact normalized brand match · 1 Part D row	27	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	192	24
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	LOKELMA open payments reported associated product	CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624	Lokelma · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	36	15

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	2053	268
Eliquis	Apixaban	2014	234
Levothyroxine Sodium	Levothyroxine Sodium	1774	225
Atorvastatin Calcium	Atorvastatin Calcium	1343	318
Gabapentin	Gabapentin	988	201
Metoprolol Succinate	Metoprolol Succinate	816	172
Sertraline Hcl	Sertraline Hcl	703	130
Tamsulosin Hcl	Tamsulosin Hcl	689	146
Metoprolol Tartrate	Metoprolol Tartrate	616	132
Amlodipine Besylate	Amlodipine Besylate	604	158
Trazodone Hcl	Trazodone Hcl	522	109
Losartan Potassium	Losartan Potassium	490	108
Escitalopram Oxalate	Escitalopram Oxalate	449	83
Finasteride	Finasteride	443	70
Lisinopril	Lisinopril	433	117
Januvia	Sitagliptin Phosphate	432	29
Mirtazapine	Mirtazapine	429	100
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	425	71
Metformin Hcl	Metformin Hcl	421	92
Pantoprazole Sodium	Pantoprazole Sodium	413	110
Omeprazole	Omeprazole	396	126
Potassium Chloride	Potassium Chloride	389	111
Divalproex Sodium	Divalproex Sodium	354	65
Spironolactone	Spironolactone	347	82
Quetiapine Fumarate	Quetiapine Fumarate	340	62
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	317	78
Carvedilol	Carvedilol	317	70
Levetiracetam	Levetiracetam	308	63
Duloxetine Hcl	Duloxetine Hcl	294	74
Clopidogrel	Clopidogrel Bisulfate	293	68
Baclofen	Baclofen	288	54
Buspirone Hcl	Buspirone Hcl	284	57
Xarelto	Rivaroxaban	283	29
Entresto	Sacubitril/Valsartan	262	26
Jardiance	Empagliflozin	259	31
Tramadol Hcl	Tramadol Hcl	255	100
Donepezil Hcl	Donepezil Hcl	248	57
Olanzapine	Olanzapine	241	42
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	230	45
Carbidopa-Levodopa	Carbidopa/Levodopa	227	36
Bumetanide	Bumetanide	223	47
Aripiprazole	Aripiprazole	208	33
Allopurinol	Allopurinol	204	36
Torsemide	Torsemide	199	43
Famotidine	Famotidine	195	72
Ropinirole Hcl	Ropinirole Hcl	194	38
Farxiga	Dapagliflozin Propanediol	192	24
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	191	82
Citalopram Hbr	Citalopram Hydrobromide	185	37
Lactulose	Lactulose	181	50
Atenolol	Atenolol	175	35
Latanoprost	Latanoprost	168	41
Hydralazine Hcl	Hydralazine Hcl	164	35
Ondansetron Hcl	Ondansetron Hcl	155	73
Doxycycline Hyclate	Doxycycline Hyclate	154	73
Oxycodone Hcl	Oxycodone Hcl	154	54
Hydrochlorothiazide	Hydrochlorothiazide	149	32
Nifedipine Er	Nifedipine	148	35
Fluoxetine Hcl	Fluoxetine Hcl	146	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	146	51
Myrbetriq	Mirabegron	143	17
Trulicity	Dulaglutide	143	28
Simvastatin	Simvastatin	139	31
Insulin Lispro Kwikpen U-100	Insulin Lispro	132	45
Isosorbide Mononitrate Er	Isosorbide Mononitrate	132	28
Prednisone	Prednisone	130	61
Arexvy	Rsvpref3 Antigen/As01e/Pf	129	124
Venlafaxine Hcl Er	Venlafaxine Hcl	129	26
Risperidone	Risperidone	127	25
Memantine Hcl	Memantine Hcl	126	23
Clonazepam	Clonazepam	120	30
Lorazepam	Lorazepam	120	43
Cephalexin	Cephalexin	119	59
Novolog Flexpen	Insulin Aspart	119	34
Midodrine Hcl	Midodrine Hcl	114	38
Rosuvastatin Calcium	Rosuvastatin Calcium	113	43
Fluticasone Propionate	Fluticasone Propionate	110	39
Insulin Aspart Flexpen	Insulin Aspart	108	36
Rexulti	Brexpiprazole	108	16
Albuterol Sulfate Hfa	Albuterol Sulfate	105	67
Amiodarone Hcl	Amiodarone Hcl	103	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	101	48
Digoxin	Digoxin	95	19
Pravastatin Sodium	Pravastatin Sodium	95	22
Pregabalin	Pregabalin	95	27
Warfarin Sodium	Warfarin Sodium	93	suppressed
Glipizide	Glipizide	91	20
Paroxetine Hcl	Paroxetine Hcl	91	20
Tradjenta	Linagliptin	87	13
Alprazolam	Alprazolam	86	20
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	86	46
Clonidine Hcl	Clonidine Hcl	85	21
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	84	41
Scopolamine	Scopolamine	84	14
Fentanyl	Fentanyl	81	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	79	40
Montelukast Sodium	Montelukast Sodium	77	21
Nystatin	Nystatin	77	40
Propranolol Hcl	Propranolol Hcl	77	15
Alendronate Sodium	Alendronate Sodium	73	17
Acetic Acid	Acetic Acid	72	15
Metolazone	Metolazone	72	16
Morphine Sulfate	Morphine Sulfate	72	39
Topiramate	Topiramate	72	11
Albuterol Sulfate	Albuterol Sulfate	71	29
Levofloxacin	Levofloxacin	70	42
Lamotrigine	Lamotrigine	68	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	68	15
Triamcinolone Acetonide	Triamcinolone Acetonide	66	34
Venlafaxine Hcl	Venlafaxine Hcl	66	14
Breo Ellipta	Fluticasone/Vilanterol	65	13
Lantus	Insulin Glargine,hum.Rec.Anlog	65	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	65	24
Bupropion Xl	Bupropion Hcl	62	17
Diltiazem 24hr Er (La)	Diltiazem Hcl	62	suppressed
Primidone	Primidone	62	18
Ssd	Silver Sulfadiazine	61	25
Valsartan	Valsartan	60	21
Sucralfate	Sucralfate	59	16
Amitriptyline Hcl	Amitriptyline Hcl	58	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	57	35
Diltiazem 24hr Er	Diltiazem Hcl	56	suppressed
Humalog Kwikpen U-100	Insulin Lispro	56	23
Breyna	Budesonide/Formoterol Fumarate	54	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	25
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	54	20
Metformin Hcl Er	Metformin Hcl	54	16
Phenytoin Sodium Extended	Phenytoin Sodium Extended	53	suppressed
Creon	Lipase/Protease/Amylase	52	suppressed
Meclizine Hcl	Meclizine Hcl	52	15
Ozempic	Semaglutide	52	17
Enalapril Maleate	Enalapril Maleate	51	suppressed
Tizanidine Hcl	Tizanidine Hcl	51	16
Clonidine	Clonidine	50	suppressed
Dapagliflozin	Dapagliflozin Propanediol	50	20
Carbidopa-Levodopa Er	Carbidopa/Levodopa	49	suppressed
Lacosamide	Lacosamide	48	suppressed
Oxcarbazepine	Oxcarbazepine	48	suppressed
Phenobarbital	Phenobarbital	48	suppressed
Santyl	Collagenase Clostridium Hist.	48	27
Clindamycin Hcl	Clindamycin Hcl	47	17
Divalproex Sodium Er	Divalproex Sodium	47	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	47	18
Xifaxan	Rifaximin	47	suppressed
Celecoxib	Celecoxib	46	17
Lidocaine Hcl	Lidocaine Hcl	46	30
Multaq	Dronedarone Hcl	46	suppressed
Mupirocin	Mupirocin	46	26
Diclofenac Sodium	Diclofenac Sodium	45	25
Sodium Chloride	0.9 % Sodium Chloride	45	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	43	17
Hydroxyzine Hcl	Hydroxyzine Hcl	43	24
Nadolol	Nadolol	43	suppressed
Novolog	Insulin Aspart	43	12
Methimazole	Methimazole	42	suppressed
Azithromycin	Azithromycin	40	27
Oxybutynin Chloride Er	Oxybutynin Chloride	40	15
Carbamazepine Er	Carbamazepine	39	suppressed
Ceftriaxone	Ceftriaxone Sodium	39	27
Clozapine	Clozapine	39	suppressed
Erythromycin	Erythromycin Base	39	15
Hydrocortisone	Hydrocortisone	39	suppressed
Nystop	Nystatin	38	30
Zonisamide	Zonisamide	38	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Fluconazole	Fluconazole	37	19
Lubiprostone	Lubiprostone	37	suppressed
Benztropine Mesylate	Benztropine Mesylate	36	suppressed
Bupropion Hcl	Bupropion Hcl	36	suppressed
Methenamine Hippurate	Methenamine Hippurate	36	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	36	32
Symbicort	Budesonide/Formoterol Fumarate	36	15
Brimonidine Tartrate	Brimonidine Tartrate	35	suppressed
Incruse Ellipta	Umeclidinium Bromide	35	suppressed
Glimepiride	Glimepiride	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	33	suppressed
Lumigan	Bimatoprost	33	suppressed
Metronidazole	Metronidazole	33	19
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	33	14
Prazosin Hcl	Prazosin Hcl	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	12
Calcitriol	Calcitriol	31	suppressed
Dutasteride	Dutasteride	31	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	31	14
Nuplazid	Pimavanserin Tartrate	31	suppressed
Ranolazine Er	Ranolazine	31	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	31	22
Clobetasol Propionate	Clobetasol Propionate	30	suppressed
Dexamethasone	Dexamethasone	30	14
Ketoconazole	Ketoconazole	30	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	14
Terazosin Hcl	Terazosin Hcl	30	suppressed
Amantadine	Amantadine Hcl	29	suppressed
Amoxicillin	Amoxicillin	29	19
Budesonide	Budesonide	29	suppressed
Linzess	Linaclotide	29	12
Lithostat	Acetohydroxamic Acid	29	suppressed
Morphine Sulfate Er	Morphine Sulfate	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	19
Cinacalcet Hcl	Cinacalcet Hcl	28	suppressed
Nitroglycerin	Nitroglycerin	28	22
Timolol Maleate	Timolol Maleate	28	suppressed
Brilinta	Ticagrelor	27	suppressed
Jentadueto	Linagliptin/Metformin Hcl	27	suppressed
Meloxicam	Meloxicam	27	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	27	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Colchicine	Colchicine	26	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	26	15
Mounjaro	Tirzepatide	26	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	26	suppressed
Dexlansoprazole Dr	Dexlansoprazole	25	suppressed
Klayesta	Nystatin	25	11
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	24	suppressed
Cyclosporine	Cyclosporine	24	suppressed
Entacapone	Entacapone	24	suppressed
Haloperidol	Haloperidol	24	suppressed
Ibuprofen	Ibuprofen	24	11
Levemir Flexpen	Insulin Detemir	24	12
Lidocaine Hcl Viscous	Lidocaine Hcl	24	suppressed
Olanzapine Odt	Olanzapine	24	suppressed
Prednisolone Acetate	Prednisolone Acetate	24	11
Vascepa	Icosapent Ethyl	24	suppressed
Irbesartan	Irbesartan	23	suppressed
Carbamazepine	Carbamazepine	22	suppressed
Daptomycin	Daptomycin	22	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Trospium Chloride Er	Trospium Chloride	22	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	21	suppressed
Humalog	Insulin Lispro	21	suppressed
Memantine Hcl Er	Memantine Hcl	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Admelog Solostar	Insulin Lispro	20	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Azelastine Hcl	Azelastine Hcl	20	12
Enulose	Lactulose	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	20	18
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Vancomycin Hcl	Vancomycin Hcl	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	19	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Cefuroxime	Cefuroxime Axetil	18	14
Dulera	Mometasone/Formoterol	18	suppressed
Ertapenem	Ertapenem Sodium	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	18	suppressed
Minoxidil	Minoxidil	18	suppressed
Pentoxifylline	Pentoxifylline	18	suppressed
Trexall	Methotrexate Sodium	18	suppressed
Ammonium Lactate	Ammonium Lactate	17	12
Ampicillin-Sulbactam	Ampicillin Sod/Sulbactam Sod	17	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	17	suppressed
Diazepam	Diazepam	17	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	17	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	17	suppressed
Gemtesa	Vibegron	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	16
Sevelamer Hcl	Sevelamer Hcl	17	suppressed
Verapamil Sr	Verapamil Hcl	17	suppressed
Ondansetron Odt	Ondansetron	16	11
Rytary	Carbidopa/Levodopa	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Fosinopril Sodium	Fosinopril Sodium	15	suppressed
Glucagon Emergency Kit	Glucagon	15	15
Verapamil Er	Verapamil Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Lorazepam Intensol	Lorazepam	14	suppressed
Meropenem-0.9% Nacl	Meropenem-0.9% Sodium Chloride	14	suppressed
Restasis Multidose	Cyclosporine	14	suppressed
Safetyglide Insulin Syringe	Syringe And Needle,insulin,1ml	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	13	suppressed
Nateglinide	Nateglinide	13	suppressed
Neupro	Rotigotine	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Zenpep	Lipase/Protease/Amylase	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Ingrezza	Valbenazine Tosylate	12	suppressed
Mirabegron Er	Mirabegron	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Sulfasalazine Dr	Sulfasalazine	12	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	11	11
Acetazolamide	Acetazolamide	11	suppressed
Estradiol	Estradiol	11	suppressed
Humira(Cf) Pen	Adalimumab	11	suppressed
Invokana	Canagliflozin	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed
Valproic Acid	Valproic Acid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$62.03 · 3 records	AstraZeneca Pharmaceuticals LP	AUSTEDO XR, BREZTRI	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error